146 related articles for article (PubMed ID: 2280672)
1. Comparison of the effect of six compactin-related compounds on cholesterol synthesis in five human cell types.
Sviridov DD; Endo A; Pavlov MYu ; Repin VS; Smirnov VN
Lipids; 1990 Nov; 25(11):685-90. PubMed ID: 2280672
[TBL] [Abstract][Full Text] [Related]
2. Time response of cholesterol synthesis inhibition by compactin-related compounds. In vitro quantitation of the "escape phenomenon".
Sviridov DD; Endo A; Pavlov MY; Repin VS
Lipids; 1993 Jun; 28(6):569-71. PubMed ID: 8355584
[TBL] [Abstract][Full Text] [Related]
3. Biochemical aspect of HMG CoA reductase inhibitors.
Endo A; Hasumi K
Adv Enzyme Regul; 1989; 28():53-64. PubMed ID: 2696346
[TBL] [Abstract][Full Text] [Related]
4. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
[TBL] [Abstract][Full Text] [Related]
5. The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
Fears R; Richards DH; Ferres H
Atherosclerosis; 1980 Apr; 35(4):439-49. PubMed ID: 7189661
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
Boogaard A; Griffioen M; Cohen LH
Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060
[TBL] [Abstract][Full Text] [Related]
7. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase.
Endo A
J Med Chem; 1985 Apr; 28(4):401-5. PubMed ID: 3981532
[No Abstract] [Full Text] [Related]
8. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.
Serajuddin AT; Ranadive SA; Mahoney EM
J Pharm Sci; 1991 Sep; 80(9):830-4. PubMed ID: 1800703
[TBL] [Abstract][Full Text] [Related]
9. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells.
Nagata Y; Hidaka Y; Ishida F; Kamei T
Biochem Pharmacol; 1990 Aug; 40(4):843-50. PubMed ID: 2167097
[TBL] [Abstract][Full Text] [Related]
10. Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitors.
Endo A
Klin Wochenschr; 1988 May; 66(10):421-7. PubMed ID: 3294493
[TBL] [Abstract][Full Text] [Related]
11. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2.
Cohen LH; Griffioen M; Havekes L; Schouten D; van Hinsbergh V; Kempen HJ
Biochem J; 1984 Aug; 222(1):35-9. PubMed ID: 6089762
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity induces a paradoxical increase in DNA synthesis in myeloid leukemia cells.
Hohl RJ; Larson RA; Mannickarottu V; Yachnin S
Blood; 1991 Mar; 77(5):1064-70. PubMed ID: 1995091
[TBL] [Abstract][Full Text] [Related]
13. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
Qin W; Infante J; Wang SR; Infante R
Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
[TBL] [Abstract][Full Text] [Related]
14. Compactin-a review.
Chakravarti R; Sahai V
Appl Microbiol Biotechnol; 2004 Jun; 64(5):618-24. PubMed ID: 15034683
[TBL] [Abstract][Full Text] [Related]
15. Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.
Haba T; Mabuchi H; Yoshimura A; Watanabe A; Wakasugi T; Tatami R; Ueda K; Ueda R; Kametani T; Koizumi J; Miyamoto S; Takeda R; Takeshita H
J Clin Invest; 1981 May; 67(5):1532-40. PubMed ID: 7229037
[TBL] [Abstract][Full Text] [Related]
16. Dihydromonacolin L and monacolin X, new metabolites which inhibit cholesterol biosynthesis.
Endo A; Hasumi K; Nakamura T; Kunishima M; Masuda M
J Antibiot (Tokyo); 1985 Mar; 38(3):321-7. PubMed ID: 3839224
[TBL] [Abstract][Full Text] [Related]
17. Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor.
Fairbanks KP; Witte LD; Goodman DS
J Biol Chem; 1984 Feb; 259(3):1546-51. PubMed ID: 6693424
[TBL] [Abstract][Full Text] [Related]
18. Regulation of plasma cholesterol by compactin and mevinolin.
Nutr Rev; 1985 Sep; 43(9):266-8. PubMed ID: 3903562
[No Abstract] [Full Text] [Related]
19. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
20. Compactin inhibits cholesterol synthesis in lymphocytes and intestinal mucosa from patients with familial hypercholesterolaemia.
Betteridge DJ; Krone W; Reckless JP; Galton DJ
Lancet; 1978 Dec 23-30; 2(8104-5):1342-3. PubMed ID: 82843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
